These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17029347)

  • 21. Evidence-based pharmacotherapy for cerebral vasospasm.
    Deshaies EM; Boulos AS; Drazin D; Popp AJ
    Neurol Res; 2009 Jul; 31(6):615-20. PubMed ID: 19108757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal treatment of cerebral vasospasm.
    Zhang YP; Shields LB; Yao TL; Dashti SR; Shields CB
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1201-11. PubMed ID: 22651990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
    Rinkel GJ; Feigin VL; Algra A; Vermeulen M; van Gijn J
    Cochrane Database Syst Rev; 2002; (4):CD000277. PubMed ID: 12519539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Amuluru K; Damodara N; El-Ghanem M; Nuoman R; Kamal N; Al-Marsoummi S; Morris NA; Dangayach NS; Mayer SA
    J Neurol Sci; 2018 Jul; 390():44-51. PubMed ID: 29801906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.
    Sillberg VA; Wells GA; Perry JJ
    Stroke; 2008 Sep; 39(9):2622-6. PubMed ID: 18658040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.
    Durrant JC; Hinson HE
    Curr Neurol Neurosci Rep; 2015; 15(2):521. PubMed ID: 25501582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
    Sakowitz OW; Unterberg AW
    Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
    Dorsch NW
    Curr Opin Crit Care; 2002 Apr; 8(2):128-33. PubMed ID: 12386513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of cisternal and ventricular lavage on cerebral vasospasm in patients suffering from subarachnoid hemorrhage: analysis of effectiveness.
    Hänggi D; Steiger HJ
    Acta Neurochir Suppl; 2011; 110(Pt 2):95-8. PubMed ID: 21125452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral vasospasm: current understanding.
    Rao GS; Muthuchellappan R
    Curr Opin Anaesthesiol; 2016 Oct; 29(5):544-51. PubMed ID: 27341013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in vasospasm treatment and prevention.
    Komotar RJ; Zacharia BE; Valhora R; Mocco J; Connolly ES
    J Neurol Sci; 2007 Oct; 261(1-2):134-42. PubMed ID: 17570400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.
    Diringer MN; Zazulia AR
    Semin Respir Crit Care Med; 2017 Dec; 38(6):760-767. PubMed ID: 29262433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 2].
    Verger Bennasar AM; Romero Kräuchi O
    Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):236-42. PubMed ID: 21608280
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of arterial vasospasm following aneurysmal subarachnoid hemorrhage.
    Dusick JR; Gonzalez NR
    Semin Neurol; 2013 Nov; 33(5):488-97. PubMed ID: 24504612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Przybycien-Szymanska MM; Ashley WW
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral Vasospasm: A Review.
    Findlay JM; Nisar J; Darsaut T
    Can J Neurol Sci; 2016 Jan; 43(1):15-32. PubMed ID: 26332908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.